Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
50%(3 trials)

Phase Distribution

Ph phase_1
1
10%
Ph phase_3
2
20%
Ph not_applicable
4
40%
Ph phase_2
2
20%
Ph phase_4
1
10%

Phase Distribution

1

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
1(10.0%)
Phase 2Efficacy & side effects
2(20.0%)
Phase 3Large-scale testing
2(20.0%)
Phase 4Post-market surveillance
1(10.0%)
N/ANon-phased studies
4(40.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(6)
Other(4)

Detailed Status

Completed6
unknown4

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (10.0%)
Phase 22 (20.0%)
Phase 32 (20.0%)
Phase 41 (10.0%)
N/A4 (40.0%)

Trials by Status

completed660%
unknown440%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
10